UnknownPhase 4Other

A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty

Sponsored by Kyunghee University Medical Center

NCT ID
NCT06113497
Target Enrollment
60 participants
Start Date
2023-11-25
Est. Completion
2025-09-30

About This Study

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty

Conditions Studied

Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified

Interventions

  • Cocktail injection

Eligibility

Age:20 Years - 80 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Diagnosed with cervical myelopathy or radiculopathy and scheduled to undergo laminoplasty
* Recorded preoperative upper limb pain (Visual Analog Scale \[- VAS\] ), neck pain (VAS), Japanese Orthopaedic Association (JOA) scores, and Neck Disability Index (NDI) scores.
* Adults aged 20 years and above, but below 80 years capable of articulating their own pain or functional abnormalities
* Cognitive function at a level that enables them to comprehend and adhere to study procedures

Exclusion Criteria:

* Previous surgical treatment of the cervical spine.
* Adolescents aged 20 years or below, pregnant individuals, or those with the potential for pregnancy.
* Hypersensitivity reactions to mixed medications used in Cocktail therapy. (morphine 5 mg, ropiva 150 mg, tamceton 40 mg, epinephrine 1 mg, ketocin 60 mg, jetiam 1 g).
* Patients who lack the capacity for medical consent or are unable to communicate effectively in a medical context.

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source